PACS vs ULS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

PACS

32.9
AI Score
VS
PACS Wins

ULS

26.8
AI Score

Investment Advisor Scores

PACS

33score
Recommendation
AVOID NEW MONEY

ULS

27score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric PACS ULS Winner
Forward P/E 15.528 24.8756 PACS
PEG Ratio 1.0347 1.3294 PACS
Revenue Growth 9.1% 5.2% PACS
Earnings Growth 51.6% 168.9% ULS
Tradestie Score 32.9/100 26.8/100 PACS
Profit Margin 4.9% 16.1% ULS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

PACS 1M: +12.6% · 3M: +4.3% ULS 1M: +11.4% · 3M: -14.2%

Current Technical Phase

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.6 · Price: $46.76

ULS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.4 · Price: $74.28

Fundamentals Snapshot

Metric PACS ULS
Market Cap — —
Forward P/E 17.1 28.5
Trailing P/E 27.9 29.5
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.5%
Operating Margin 0.1% 0.2%
EPS 1.71 2.49
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.